| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919586 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
This pilot trial suggests that head and neck ART dosimetrically outperforms IMRT. IGRT that leverages conventional PTV margins does not improve dosimetry. One properly timed replan delivers the majority of achievable dosimetric improvement. The clinical impact of ART must be confirmed by future trials.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David L. Schwartz, Adam S. Garden, Shalin J. Shah, Gregory Chronowski, Samir Sejpal, David I. Rosenthal, Yipei Chen, Yongbin Zhang, Lifei Zhang, Pei-Fong Wong, John A. Garcia, K. Kian Ang, Lei Dong,